Sulfonyl Substituted 1H-Indoles as Ligands for the 5-Hydroxytryptamine Receptors
申请人:McDevitt Robert E.
公开号:US20070203120A1
公开(公告)日:2007-08-30
The present invention is directed to compounds of Formula I:
which are modulators of the 5-hydroxtryptamine-6 and 5-hydroxytryptamine-2A receptors and which are inhibitors of norepinephrine reuptake. The compounds of the invention, and pharmaceutical composition thereof, are useful in the treatment of disorders related to or associated with the 5-hydroxytryptamine-6 and 5-hydroxtryptamine-2A receptors or with norepinephrine reuptake inhibition.
Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles
作者:Gavin D. Heffernan、Richard D. Coghlan、Eric S. Manas、Robert E. McDevitt、Yanfang Li、Paige E. Mahaney、Albert J. Robichaud、Christine Huselton、Peter Alfinito、Jenifer A. Bray、Scott A. Cosmi、Grace H. Johnston、Thomas Kenney、Elizabeth Koury、Richard C. Winneker、Darlene C. Deecher、Eugene J. Trybulski
DOI:10.1016/j.bmc.2009.09.023
日期:2009.11
The discovery of a series of 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles, dual acting norepinephrine reuptake inhibitors (NRIs) and 5-HT2A receptor antagonists, is described. The synthesis and structure-activity relationship (SAR) of this novel series of compounds is also presented. (C) 2009 Elsevier Ltd. All rights reserved.
SUBSTITUTED-3-SULFONYLINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
申请人:Wyeth
公开号:EP1931640A2
公开(公告)日:2008-06-18
SULFONYL SUBSTITUTED 1H-INDOLES AS LIGANDS FOR THE 5-HYDROXYTRYPTAMINE RECEPTORS